Mycenax becomes Taiwan's first CDMO company to complete the CH... - 18 May 2021 13:33

TAIPEI, May 18, 2021 /PRNewswire-AsiaNet/ -- Mycenax (TWSE: 4726) becomes one of the first CDMO companies in Asia to adapt the Beacon Optofluidic system to cell line development services. Mycenax adopted Beacon® Optofluidic System, a high throughput selection system for single-cell clonin...

  Sante Laboratories and Bioarc announce strategic partnership t... - 18 May 2021 07:43

AUSTIN, Texas, May 18, 2021 /PRNewswire-AsiaNet/ -- -- World-class science companies combining resources and expertise to commercialize therapeutic cannabinoid pharmaceutical products to global market In a move destined to shape the global growth and evolution of the medicinal cannabinoid indu...

  ISMRM Awards Gold Medals At Annual Meeting And Announces New P... - 18 May 2021 01:00

CONCORD, Calif., May 17, 2021 /PRNewswire-AsiaNet/ -- The International Society for Magnetic Resonance in Medicine (ISMRM) is holding its Annual Meeting this week and will recognize several achievements with prestigious awards. The Gold Medal award is the organization's highest honor and is award...

  INOVIO Announces Appointment Of Roger Dansey, M.D., to its Boa... - 17 May 2021 22:00

PLYMOUTH MEETING, Pa., May 17, 2021 /PRNewswire-AsiaNet/ -- -- Dr. Dansey, Seagen's Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development -- Appointment of industry leader in drug development expands the Board's diverse industry, clinical development, research and co...

  FINAL RESULTS OF BIOAVAILABILITY STUDY OF PHEBRA’S ORAL ARSENI... - 14 May 2021 12:01

SYDNEY, MAY 14 /Medianet International-AsiaNet/ -- Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference. The abstract bui...

  Improving Cancer Survival Prediction: A New Approach with EpiV... - 14 May 2021 03:03

PROVIDENCE, R.I., May 14, 2021 /PRNewswire-AsiaNet/ -- EpiVax Therapeutics, Inc. ("EVT") announces the publication "Multi–step screening of neoantigens' HLA and TCR–interfaces improves prediction of survival" in Scientific Reports ( https://c212.net/c/link/?t=0&l=en&o=3162949-1&h=2804976128&u=https%3A...

  LimaCorporate Announces 1st Surgery Using Physica System Trabe... - 13 May 2021 22:00

SAN DANIELE DEL FRIULI, Italy, May 13, 2021 /PRNewswire-AsiaNet/ -- LimaCorporate ushers in a new age of collaboration and innovation with the 1st surgery with Physica system Trabecular Titanium(TM) (TT) Tibial Plate. Logo - https://mma.prnewswire.com/media/997351/LimaCorporate_Logo.jpg On April 29th, Dr. ...

  Semaglutide in people with obesity: boosts wellbeing and abili... - 13 May 2021 15:00

BAGSVAERD, Denmark, May 13, 2021 /PRNewswire-AsiaNet/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-...

  Huma raises $130 million financing to scale its digital health... - 12 May 2021 10:01

LONDON and NEW YORK, May 12, 2021, /PRNewswire-AsiaNet/-- The investment arms of leading health and technology companies, Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever and the PE fund HAT, are financing Huma to bring proactive, predictive care to all. Huma Therapeutics [http://www.hum...

  PMB and CEA Announce the Commissioning of iMiGiNE at Frederic ... - 12 May 2021 08:45

PEYNIER, France, May 12, 2021 /PRNewswire-AsiaNet/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020. This disruptive system will revolutionize the radiopharmaceutical production, acces...